Brief: Torrent Pharma Says USFDA Has Issued EIR With VAI Classification On Pithampur Facility
Nov 22 (Reuters) - Torrent Pharmaceuticals Ltd
TORP.NS :
* TORRENT PHARMA -UPDATE ON INSPECTION CONDUCTED BY USFDA
FOR CO'S
FACILITY AT PITHAMPUR
* TORRENT PHARMA - USFDA HAS ISSUED EIR WITH VOLUNTARY
ACTION
INDICATED CLASSIFICATION ON FACILITY
* TORRENT PHARMA - INSPECTION HAS NOW BEEN SUCCESSFULLY
CLOSED BY
USFDA
Source text: ID:nBSE9Qc3fm
Further company coverage: TORP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Torrent Pharmaceuticals
See all newsHSBC sees steady growth for India healthcare; raise TP on Dr. Reddy's
India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand
Brief: Torrent Pharma Q2 Consol Net Profit 5.34 Billion Rupees
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says
India's Torrent Pharma Q2 earnings to get an acquisition lift, Nomura says